Rapoden 10 mg (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 8 weeks, most ulcers healed within 8 weeks; however, healing time may occasionally vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 6 weeks, most ulcers healed within 6 weeks; however, healing time may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute gastritis and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily at bedtime. In clinical trials with treatment for up to 2 weeks, most lesions healed within 2 weeks; however, healing time may occasionally vary among patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose of lafutidine is 10mg per dose, administered orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose twice daily.

This drug should not be used in patients with allergies to certain components. As it contains lactose, caution is required for patients with lactose intolerance or related genetic diseases. It is also safest for those with allergies to soybean oil, soy, or peanuts not to take this drug. Patients who have had a drug allergy in the past, or those with liver and kidney function issues, patients undergoing dialysis, and elderly individuals should use this medication cautiously. Caution is particularly necessary for patients with abnormalities in fat metabolism, such as hyperlipidemia, diabetic dyslipidemia, and pancreatitis. This drug may cause serious allergic reactions, liver dysfunction, and blood cell reduction, so if symptoms occur, use should be discontinued immediately and medical consultation should be sought. Mild side effects such as headaches, indigestion, nausea, and constipation have also been reported, so if these symptoms persist, it's important to inform a healthcare provider. In cases where a malignant tumor is suspected, examinations should be conducted before the use of this drug, and if gastric cancer is confirmed, use should be discontinued. If treatment is found to be ineffective, it is advisable to switch to other therapeutic methods. For patients at risk of fat overload, blood lipid levels should be regularly monitored while adjusting the dosage. For elderly patients, as bodily functions may be decreased, dosage and intervals should be adjusted, and their condition should be observed. For patients undergoing dialysis, the drug concentration may increase, so it should be started at a low dose and used cautiously. Pregnant women or those who might become pregnant should take this medication under a doctor's guidance, and nursing mothers are advised to avoid its use. Safety in children has not been sufficiently confirmed, so it is preferable not to use this medication in children. This drug should be kept out of reach of children, and stored in its original container to prevent misuse or quality deterioration.

• Shock
• anaphylactic symptoms
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication is prone to be affected by air and humidity, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle